Milestone Pharmaceuticals
MIST----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Milestone Pharmaceuticals(MIST) predict that the Revenue is 238 K (--%), Miss estimate;the EBIT is -23.66 M (-15.3%), Miss estimate;the EPS is -0.2 (+35.48%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.00B--
0.03B--
-0.02B--%
EBITMiss expectations
-0.02B15.30%
-0.02B15.70%
-0.01B31.00%
EPSMiss expectations
-0.235.48%
0.19161.29%
-0.3900125.81%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf